發(fā)布時(shí)間：2018-02-28 08:22

  本文關(guān)鍵詞： 急性胰腺炎 復(fù)發(fā) 初發(fā) Meta分析　出處：《青島大學(xué)》2017年碩士論文　論文類型：學(xué)位論文

【摘要】：目的:復(fù)發(fā)性急性胰腺炎(RAP)是急性胰腺炎(AP)中的一種特殊臨床類型,如何有效預(yù)防AP復(fù)發(fā)成為臨床研究的重要課題。本文旨在探討我國(guó)復(fù)發(fā)性急性胰腺炎(RAP)的臨床特點(diǎn)及發(fā)病的高危因素,為今后RAP防治工作提供一定的參考依據(jù)。方法:以急性胰腺炎(AP)、復(fù)發(fā)、病因的中英文為檢索詞,計(jì)算機(jī)檢索Pubmed、Medline、EMBASE、Science Direct、Cochrane Library、CBM、中國(guó)知網(wǎng)、萬(wàn)方數(shù)據(jù)庫(kù)及維普數(shù)據(jù)庫(kù),收集2001年1月至2016年12月公開(kāi)發(fā)表的有關(guān)RAP發(fā)病因素及臨床特征的臨床對(duì)照研究。由2名研究者按照預(yù)先制定的納入和排除標(biāo)準(zhǔn),獨(dú)立的篩選文獻(xiàn)、提取研究資料,根據(jù)NOS評(píng)分對(duì)納入文獻(xiàn)方法學(xué)質(zhì)量進(jìn)行評(píng)價(jià),采用Rev Man 5.3軟件進(jìn)行文獻(xiàn)數(shù)據(jù)整合及發(fā)表偏倚檢測(cè)。固定或隨機(jī)效應(yīng)模型的選擇由各研究間異質(zhì)性大小決定,二分類變量采用比值比(OR)及其95%可信區(qū)間(95%CI)表示。結(jié)果:共納入16篇文獻(xiàn),病例總數(shù)3980例(復(fù)發(fā)組1231例,初發(fā)組2749例),其中11篇研究詳細(xì)報(bào)道AP復(fù)發(fā)率的情況,本文統(tǒng)計(jì)結(jié)果顯示AP治愈后復(fù)發(fā)率為24.25%。將復(fù)發(fā)組(RAP)與初發(fā)組(AP)的發(fā)病原因進(jìn)行比較,高脂血癥是AP復(fù)發(fā)的危險(xiǎn)因素(OR=2.16,95%CI 1.34~3.49,P=0.002)。研究發(fā)現(xiàn),我國(guó)近10余年AP病因構(gòu)成仍以膽系疾病為主,膽源性因素與AP的發(fā)作密切相關(guān),但不是AP復(fù)發(fā)的高危因素,AP組與RAP組膽源性因素所占比重?zé)o統(tǒng)計(jì)學(xué)差異(OR=1.19,95%CI 0.77~1.85,P=0.44)。分別合并兩組人群酒精、飲食等因素的臨床數(shù)據(jù),均未見(jiàn)統(tǒng)計(jì)學(xué)差異(OR=1.24,95%CI 0.89~1.72,P=0.21)、(OR=0.69,95%CI 0.45~1.05,P=0.08),上述因素并非導(dǎo)致AP復(fù)發(fā)的高危風(fēng)險(xiǎn)因素。研究發(fā)現(xiàn)膽囊切除術(shù)后仍存在AP復(fù)發(fā)的情況,兩組差異無(wú)統(tǒng)計(jì)學(xué)意義(OR=1.74,95%CI 0.95~3.18,P=0.07)。合并數(shù)據(jù)分析,復(fù)發(fā)組較初發(fā)組出現(xiàn)黃疸、局部并發(fā)癥的情況多,復(fù)發(fā)組重癥患者比例相對(duì)較高,差異有統(tǒng)計(jì)學(xué)意義(OR=1.61,95%CI 1.16~2.23,P=0.005)、(OR=1.60,95%CI 1.15~2.22,P=0.005)、(OR=1.42,95%CI 1.14~1.76,P=0.001)。AP復(fù)發(fā)與年齡、性別無(wú)明顯相關(guān)性,高齡不是導(dǎo)致AP復(fù)發(fā)的高危因素(OR=0.73,95%CI 0.34~1.57,P=0.42)、(OR=0.97,95%CI 0.83~1.13,P=0.68)。RAP組中特發(fā)性因素所占比重小于AP組,差異有統(tǒng)計(jì)學(xué)意義(OR=0.57,95%CI 0.44~0.72,P0.05)。結(jié)論:高脂血癥為AP復(fù)發(fā)的重要危險(xiǎn)因素,膽源性因素在RAP病因中仍占較高比例,但并非導(dǎo)致復(fù)發(fā)的高危因素。復(fù)發(fā)組患者病情相對(duì)重,較易發(fā)生重癥急性胰腺炎(SAP)的情況,行膽囊切除術(shù)后AP仍可復(fù)發(fā),RAP組中特發(fā)性因素所占比重相對(duì)小。積極尋找病因及針對(duì)病因進(jìn)行早期治療是治療及預(yù)防胰腺炎復(fù)發(fā)的關(guān)鍵所在。
[Abstract]:Objective: recurrent acute pancreatitis (rapp) is a special clinical type of acute pancreatitis. How to effectively prevent the recurrence of AP has become an important subject in clinical research. This article aims to explore the clinical characteristics and high risk factors of recurrent acute pancreatitis in China. Methods: according to the Chinese and English key words of acute pancreatitis, recurrence and etiology, we searched PubmedMedline EMBASE Direct Science Direct Cochrane Library CBM, China knowledge Network, Wanfang Database and Weip Database. From January 2001 to December 2016, a clinical controlled study on the pathogenesis and clinical characteristics of RAP was published. According to the pre-established criteria of inclusion and exclusion, two researchers extracted the data from the independent screening literature. According to the NOS score, the quality of the included literature methodology was evaluated, and the data integration and publication bias detection were performed with Rev Man 5.3 software. The choice of fixed or random effect models was determined by the heterogeneity of each study. Results: a total of 16 literatures were included, with a total of 3 980 cases (1231 cases of recurrence and 2 749 cases of initial onset). Among them, 11 studies reported the recurrence rate of AP in detail. The statistical results show that the recurrence rate of AP after cure is 24.25.The etiology of AP in relapsing group was compared with that in primary group. Hyperlipidemia was the risk factor of AP recurrence. The risk factor of AP recurrence was 2.1695 CI 1.34 ~ 3.49% PX 0.002. It was found that the etiology of AP in China was still mainly caused by biliary diseases in recent 10 years. Biliary factors were closely related to AP attack, but there was no significant difference in the proportion of biliary factors between AP group and RAP group. There was no statistical difference in OR1.2495CI 0.891.72P0. 21. There was no high risk factor for AP recurrence. These factors were not high risk factors for AP recurrence. The study found that there was still AP recurrence after cholecystectomy, and there was no significant difference between the two groups in terms of OR1.7495 CI 0.95C3.18P0.070.Combined data analysis was performed. The results showed that there was no significant difference between the two groups in AP recurrence after cholecystectomy, and there was no significant difference between the two groups. The results were as follows: (1) there was no significant difference between the two groups in terms of AP recurrence after cholecystectomy. The incidence of jaundice and local complications in the recurrent group was higher than that in the initial group, and the proportion of severe patients in the relapsing group was relatively high. The difference was statistically significant. There was no significant correlation between the recurrence and age and sex. Old age is not a high risk factor for AP recurrence. The proportion of idiopathic factors in the OR0.7395CI 0.341.57 CI 0.831.13P0.68P0.68. rap group is lower than that in the AP group, and the difference is statistically significant. Conclusion: hyperlipidemia is an important risk factor for AP recurrence. Choledochogenic factors still account for a high proportion in the etiology of RAP, but they are not high risk factors for recurrence. After cholecystectomy, the proportion of idiopathic factors in AP can still recur rap group is relatively small. It is the key to treat and prevent the recurrence of pancreatitis by actively seeking the etiology and early treatment.
【學(xué)位授予單位】：青島大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：R576

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 楊玉民;;不同手術(shù)方式治療急性膽源性胰腺炎的價(jià)值比較[J];臨床醫(yī)學(xué)研究與實(shí)踐;2017年02期

2 蒯小玲;丁海芳;張健峰;劉肇修;管程齊;毛振彪;;復(fù)發(fā)性急性胰腺炎危險(xiǎn)因素分析[J];胃腸病學(xué);2016年12期

3 劉鑫;張久聰;康生朝;汪泳;鄧尚新;耿聞男;張方信;馮娟;;ERCP在急性復(fù)發(fā)性胰腺炎病因診斷中的臨床研究[J];西北國(guó)防醫(yī)學(xué)雜志;2016年10期

4 牛蕾;葛春;;急性復(fù)發(fā)性胰腺炎與高脂血癥的互為因果關(guān)系及臨床特點(diǎn)[J];世界華人消化雜志;2016年30期

5 劉春艷;勾小菲;魏菲;呼渭華;;急性胰腺炎復(fù)發(fā)的病因及臨床分析[J];中國(guó)現(xiàn)代醫(yī)藥雜志;2016年06期

6 季鈞淘;張兟;辛磊;李兆申;;復(fù)發(fā)性急性胰腺炎診斷與治療研究進(jìn)展[J];中華胰腺病雜志;2016年03期

7 呂坤;陳翔;;復(fù)發(fā)性膽源性胰腺炎的臨床特點(diǎn)及誘發(fā)因素分析[J];臨床肝膽病雜志;2016年01期

8 邵慶亮;;膽源性胰腺炎患者術(shù)后復(fù)發(fā)的相關(guān)危險(xiǎn)因素與預(yù)后分析[J];環(huán)球中醫(yī)藥;2015年S1期

9 易潮方;方永華;陳柱;;急性復(fù)發(fā)性胰腺炎的臨床特點(diǎn)與病因探討[J];吉林醫(yī)學(xué);2015年08期

10 溫彥麗;郝婷婷;戴光榮;馮義朝;;急性復(fù)發(fā)性胰腺炎288例病因分析[J];陜西醫(yī)學(xué)雜志;2015年01期

相關(guān)碩士學(xué)位論文 前3條

1 韓嘯;復(fù)發(fā)性急性胰腺炎的致病因素及相關(guān)臨床指標(biāo)變化情況分析[D];大連醫(yī)科大學(xué);2015年

2 林杰;回顧性研究:復(fù)發(fā)性急性胰腺炎的病因及相關(guān)分析[D];福建醫(yī)科大學(xué);2014年

3 張瑜;復(fù)發(fā)性急性胰腺炎致病高危因素及預(yù)后分析[D];山西醫(yī)科大學(xué);2013年

，

本文編號(hào)：1546539